The study revealed that the accumulation of amylin‐Aβ complex in the brain of AD patients with T2DM activates the production of cytokines such as IL‐1β, which in turn enhances neuroinflammatory immune responses leading to gradual degeneration of neurons (Verma et al., 2016). This evidence concerns the gene IAPP and Alzheimer disease.